Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 July 2021 | Story Rulanzen Martin | Photo Supplied
For Prof Anthea van Jaarsveld, the balance between science, theoretical and practical experience is important for a balanced industry.

Her unique approach to Drama and Theatre Arts makes Prof Anthea van Jaarsveld the most suitable person to take over the reins as Head of the UFS Department of Drama and Theatre Arts. Prof Van Jaarsveld was officially appointed as head of this special department this year. 

The Department of Drama at the UFS is one of the biggest in the country, and according to Prof Van Jaarsveld it is also the best, because the department produces some of the finest in the industry. Her main goal as head of department is to bring about a subtle change in emphasis that will ultimately make a real contribution to employability, a greater variety of job opportunities, and practice-orientated research. “My ultimate goal is therefore an approach within which academy and practice will find each other for the benefit of both,” says Prof Van Jaarsveld.

Science, theatre and drama collide 

Prof Van Jaarsveld has a scientific approach to drama and theatre arts. She never acted professionally. It is precisely from a scientific perspective that her knowledge of the theorising and contextualisation of drama text, theatre concepts, and the film industry is applied in order to maintain a balance in a profession where the emphasis on practical experience is overwhelming.  

She studied Drama at the UFS and was also employed as Drama teacher at Eunice Girls’ School. Following this, she started working as lecturer in the Department of Afrikaans and Dutch. “There I focused on the Drama genre in Afrikaans; therefore, I never actually left drama and theatre,” says Prof Van Jaarsveld. In 2018, she returned to the Department of Drama. 

Upon her return to the department where she started her studies, her aim is to ensure that the department again complies with the total package of the UFS and to make sure “that our students are prepared for a multifaceted and dynamic industry on a practical level”. 

Prof Van Jaarsveld took over from Prof Nico Luwes who retired in 2019. 

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept